JFGIW
TEVA icon

Johnson Financial Group Inc (Wisconsin)’s Teva Pharmaceuticals TEVA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-151
Closed -$2.67K – 950
2024
Q4 		$2.67K Buy
151
+131
+655% +$2.38K ﹤0.01% 788
2024
Q3 		$361 Hold
20
– – ﹤0.01% 899
2024
Q2 		$325 Hold
20
– – ﹤0.01% 812
2024
Q1 		$283 Hold
20
– – ﹤0.01% 743
2023
Q4 		$209 Buy
+20
New +$187 ﹤0.01% 876
2014
Q2 		– Sell
-130
Closed -$7K – 722
2014
Q1 		$7K Buy
+130
New +$6.01K ﹤0.01% 614
2013
Q4 		– Sell
-300
Closed -$11K – 729
2013
Q3 		$11K Sell
300
-1,510
-83% -$58.9K ﹤0.01% 553
2013
Q2 		$71K Buy
+1,810
New +$70.5K 0.02% 375

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s TEVA Position: Q1 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 151 shares — an estimated $2.67K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $71K in Q2 2013. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 151 Teva Pharmaceuticals shares in Q1 2025, an estimated $2.67K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Teva Pharmaceuticals position peaked at $71K in Q2 2013.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2025, filed 15 May 2025.